What's New

Eye Vitamins Available!

Date: Jun 7, 2017



Age-related macular degeneration, or ARMD, is one of the most severe ocular conditions, robbing patients of central vision during the latter decades of their lives.  Almost two million Americans have reduced vision due to advanced ARMD and are unable to perform common tasks and enjoy simple pleasures.

There are different stages of AMD.  It is possible to have AMD in one eye only, or to have one eye with a later stage of AMD than the other.  For those people who have early AMD in one eye and no signs of AMD in the other eye, about five percent will develop advanced AMD after 10 years.  For people who have early AMD in both eyes, about 14 percent will develop advanced AMD in at least one eye after 10 years.

In 2006, the AREDS (Age-Related Eye Disease Study) research group, which is based at NIH’s National Eye Institute, began a second study called AREDS2 to determine if they could improve the original AREDS formulation.   This study was a major clinical study, and the goal of the AREDS2 was to determine if altering the original AREDS antioxidant and zinc formulation would further reduce the risk of moderate to advanced AMD.   The study was an independent 5 year clinical study with 4,200 participants. 

Based on study results, the NEI proposed a modification to the original AREDS supplement formula as follows: Vitamin C 500 mg, vitamin E 400 IU, zinc 80 mg, copper 2mg, lutein 10mg and zaexanthin 2mg. 

By closely working with Arnet Labs and following the new recommendations and guidelines of the AREDS2 study, Dr. Miguel Busquets, Dr. Brian Jewart and Dr. Christopher Seebruck have helped pioneer two vitamin formulas specifically designed for their own patients’ needs; one formula for low risk AMD and one formula for high risk AMD.  They are now working directly with this new manufacturer that responds immediately to our doctors’ requests.  This unique relationship enables the doctors at AIO to rapidly update the vitamin formulations necessary for your eye care needs based on current research and recommendations, which is something that is not possible with mass-produced brands.

The doctors are pleased to offer this convenience to our patients.  The above formulations are available in our offices or via mail order.  As we have discontinued our relationship with Douglas Laboratories, we are no longer recommending purchase of their products since we cannot verify their integrity.  As an AIO patient, you can have the confidence that your surgeon is using the most advanced technologies, products and procedures to help you attain your vision goals. Investing in research is just another way AIO demonstrates our ongoing commitment to achieving the best results for your vision care.

For more information on how to order your new supplements, please call 888-634-9800 or visit our office.